HR
Healthcare Realty Trust Incorporated
There isn't enough reported data to score HR yet.
HR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
HR's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for real estate companies like HR.
HR PE Valuation
HR has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 421x next year's earnings.
HR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect HR to return to profit, with revenue holding steady.
HR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.05 | — |
| Q3 2026 | -$0.14 | +$0.95 |
| Q2 2026 | -$0.26 | +$0.92 |
| Q1 2026 | -$0.58 | +$0.54 |
| Q4 2025 | -$0.71 | +$1.10 |
| Q3 2025 | -$1.09 | +$0.49 |
| Q2 2025 | -$1.18 | +$0.32 |
| Q1 2025 | -$1.12 | +$0.21 |
| Q4 2024 | -$1.81 | -$1.07 |
HR is still losing money, but far less than before: $0.14 per share over the past year, against $1.81 at its worst in late 2024.
HR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $286.6M | -3.7% |
| Q2 2026 | $281.8M | -5.3% |
| Q1 2026 | $279M | -6.7% |
| Q4 2025 | $286.3M | -7.6% |
| Q3 2025 | $297.8M | -5.6% |
| Q2 2025 | $297.5M | -5.9% |
| Q1 2025 | $299M | -8.5% |
| Q4 2024 | $309.8M | -6.3% |
HR's revenue has slid since its 2023 peak: $287M last quarter, down 3.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2022 | 9% | -2.5 points |
| Q4 2021 | 6.1% | -4.9 points |
| Q3 2021 | 11% | +0.4 points |
| Q2 2021 | 2.8% | -4.6 points |
| Q1 2021 | 11% | +3 points |
| Q4 2020 | 11% | +6.1 points |
| Q3 2020 | 11% | N/A |
| Q2 2020 | 7.4% | N/A |
HR's operating margin was 9% last quarter, down 2.5 points from the same quarter a year ago.
HR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $122.3M | +7.5% |
| Q2 2026 | $142.2M | -13% |
| Q1 2026 | $52.9M | +11% |
| Q4 2025 | $132.3M | -4.1% |
| Q3 2025 | $113.8M | -4.7% |
| Q2 2025 | $163.2M | -2.9% |
| Q1 2025 | $47.8M | -37% |
| Q3 2024 | $119.3M | +1.5% |
HR's free cash flow was $450M over the past year, down 2.8% from the year before. Free cash flow isn't a meaningful measure for real estate companies like HR.
HR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -1.7M shares |
| 1 year | -2.7% | -9.3M shares |
| 3 years | -10% | -38.3M shares |
| 5 years | +53% | +118M shares |
| Available history | +63% | +131M shares |
HR has 341M diluted shares, down 2.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $43,000 |
| Q2 2026 | $731,000 |
| Q1 2026 | $2M |
| Q4 2025 | $379,000 |
| Q3 2025 | $2.9M |
| Q2 2025 | $498,000 |
| Q1 2025 | $215,000 |
| Q4 2024 | $8.6M |
HR has spent almost nothing on buybacks in the past year.
HR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2022 | 8.5x | High |
| Q4 2021 | 8.2x | High |
| Q3 2021 | 8.3x | High |
| Q2 2021 | 8.2x | High |
| Q1 2021 | 7.9x | High |
| Q4 2020 | 7.8x | High |
| Q3 2020 | 7.7x | High |
| Q2 2020 | 7.7x | High |
HR's net debt is about 8.5 years of its operating earnings (EBITDA), up from 7.9 years a year ago. Net leverage isn't a meaningful measure for real estate companies like HR.
HR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.1 | Neutral |
| Stochastic | 54.4 | Neutral |
HR's weekly RSI is 53 (neutral) and its Stochastic is 54 (neutral).
HR PE vs Real Estate Sector
| Metric | HR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
HR has no meaningful PE right now: it lost money over the past year.
HR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.1 | 5.7% above |
| 20 week MA | $19.2 | 0.2% below |
| 50 week MA | $18.6 | 2.8% above |
| 100 week MA | $17.6 | 8.6% above |
| 200 week MA | $17.4 | 9.9% above |
HR's trend is mixed: it's above four of its five weekly moving averages, and 9.9% above its 200-week average.
HR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.9 | $29.5 | -10% |
| 2021 | $29.5 | $31.2 | +5.8% |
| 2022 | $31.2 | $18.8 | -40% |
| 2023 | $18.8 | $17.2 | -8.4% |
| 2024 | $17.2 | $16.9 | -2.1% |
| 2025 | $16.9 | $16.9 | +0.3% |
| 2026 YTD | $16.9 | $19.2 | +13% |
HR has finished lower in four of the last six years. It's up 13% so far in 2026.